Roche €1bn leads corporates’ charge to sub-curve pricing
Superlatives failed bankers today and they just had to laugh as five companies charged into the European bond market and all achieved the highly successful issues that have become the norm in recent weeks.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts